1487 related articles for article (PubMed ID: 18063923)
1. The immune effects of TRYCATs (tryptophan catabolites along the IDO pathway): relevance for depression - and other conditions characterized by tryptophan depletion induced by inflammation.
Maes M; Mihaylova I; Ruyter MD; Kubera M; Bosmans E
Neuro Endocrinol Lett; 2007 Dec; 28(6):826-31. PubMed ID: 18063923
[TBL] [Abstract][Full Text] [Related]
2. The new '5-HT' hypothesis of depression: cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression.
Maes M; Leonard BE; Myint AM; Kubera M; Verkerk R
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Apr; 35(3):702-21. PubMed ID: 21185346
[TBL] [Abstract][Full Text] [Related]
3. Increased indoleamine 2,3-dioxygenase (IDO) activity and elevated serum levels of tryptophan catabolites in patients with chronic kidney disease: a possible link between chronic inflammation and uraemic symptoms.
Schefold JC; Zeden JP; Fotopoulou C; von Haehling S; Pschowski R; Hasper D; Volk HD; Schuett C; Reinke P
Nephrol Dial Transplant; 2009 Jun; 24(6):1901-8. PubMed ID: 19155537
[TBL] [Abstract][Full Text] [Related]
4. Somatization, but not depression, is characterized by disorders in the tryptophan catabolite (TRYCAT) pathway, indicating increased indoleamine 2,3-dioxygenase and lowered kynurenine aminotransferase activity.
Maes M; Galecki P; Verkerk R; Rief W
Neuro Endocrinol Lett; 2011; 32(3):264-73. PubMed ID: 21712776
[TBL] [Abstract][Full Text] [Related]
5. Genetic and hormonal regulation of tryptophan kynurenine metabolism: implications for vascular cognitive impairment, major depressive disorder, and aging.
Oxenkrug GF
Ann N Y Acad Sci; 2007 Dec; 1122():35-49. PubMed ID: 18077563
[TBL] [Abstract][Full Text] [Related]
6. IDO and interferon-alpha-induced depressive symptoms: a shift in hypothesis from tryptophan depletion to neurotoxicity.
Wichers MC; Koek GH; Robaeys G; Verkerk R; Scharpé S; Maes M
Mol Psychiatry; 2005 Jun; 10(6):538-44. PubMed ID: 15494706
[TBL] [Abstract][Full Text] [Related]
7. Neuronal localization of indoleamine 2,3-dioxygenase in mice.
Roy EJ; Takikawa O; Kranz DM; Brown AR; Thomas DL
Neurosci Lett; 2005 Oct; 387(2):95-9. PubMed ID: 16076525
[TBL] [Abstract][Full Text] [Related]
8. Dramatic changes in oxidative tryptophan metabolism along the kynurenine pathway in experimental cerebral and noncerebral malaria.
Sanni LA; Thomas SR; Tattam BN; Moore DE; Chaudhri G; Stocker R; Hunt NH
Am J Pathol; 1998 Feb; 152(2):611-9. PubMed ID: 9466588
[TBL] [Abstract][Full Text] [Related]
9. NFκB-dependent increase of kynurenine pathway activity in human placenta: inhibition by sulfasalazine.
Dharane Neé Ligam P; Manuelpillai U; Wallace E; Walker DW
Placenta; 2010 Nov; 31(11):997-1002. PubMed ID: 20884048
[TBL] [Abstract][Full Text] [Related]
10. Induction of indolamine 2,3-dioxygenase and kynurenine 3-monooxygenase in rat brain following a systemic inflammatory challenge: a role for IFN-gamma?
Connor TJ; Starr N; O'Sullivan JB; Harkin A
Neurosci Lett; 2008 Aug; 441(1):29-34. PubMed ID: 18584961
[TBL] [Abstract][Full Text] [Related]
11. Regulatory role of tryptophan degradation pathway in HLA-G expression by human monocyte-derived dendritic cells.
López AS; Alegre E; LeMaoult J; Carosella E; González A
Mol Immunol; 2006 Jul; 43(14):2151-60. PubMed ID: 16490253
[TBL] [Abstract][Full Text] [Related]
12. Indoleamine 2,3-dioxygenase-dependent tryptophan metabolites contribute to tolerance induction during allergen immunotherapy in a mouse model.
Taher YA; Piavaux BJ; Gras R; van Esch BC; Hofman GA; Bloksma N; Henricks PA; van Oosterhout AJ
J Allergy Clin Immunol; 2008 Apr; 121(4):983-91.e2. PubMed ID: 18179817
[TBL] [Abstract][Full Text] [Related]
13. Effects of immune activation on quinolinic acid and neuroactive kynurenines in the mouse.
Saito K; Markey SP; Heyes MP
Neuroscience; 1992 Nov; 51(1):25-39. PubMed ID: 1465184
[TBL] [Abstract][Full Text] [Related]
14. A mechanism of quinolinic acid formation by brain in inflammatory neurological disease. Attenuation of synthesis from L-tryptophan by 6-chlorotryptophan and 4-chloro-3-hydroxyanthranilate.
Heyes MP; Saito K; Major EO; Milstien S; Markey SP; Vickers JH
Brain; 1993 Dec; 116 ( Pt 6)():1425-50. PubMed ID: 8293279
[TBL] [Abstract][Full Text] [Related]
15. Elevated Expression of indoleamine 2,3-dioxygenase (IDO) and accumulation of kynurenic acid in the pathogenesis of STZ-induced diabetic cataract in Wistar rats.
Kanth VR; Lavanya K; Srinivas J; Raju TN
Curr Eye Res; 2009 Apr; 34(4):274-81. PubMed ID: 19373575
[TBL] [Abstract][Full Text] [Related]
16. The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression.
Müller N; Schwarz MJ
Mol Psychiatry; 2007 Nov; 12(11):988-1000. PubMed ID: 17457312
[TBL] [Abstract][Full Text] [Related]
17. Deficit Schizophrenia Is Characterized by Defects in IgM-Mediated Responses to Tryptophan Catabolites (TRYCATs): a Paradigm Shift Towards Defects in Natural Self-Regulatory Immune Responses Coupled with Mucosa-Derived TRYCAT Pathway Activation.
Kanchanatawan B; Sirivichayakul S; Ruxrungtham K; Carvalho AF; Geffard M; Anderson G; Maes M
Mol Neurobiol; 2018 Mar; 55(3):2214-2226. PubMed ID: 28290151
[TBL] [Abstract][Full Text] [Related]
18. Chronic Mild Stress Alters Kynurenine Pathways Changing the Glutamate Neurotransmission in Frontal Cortex of Rats.
Martín-Hernández D; Tendilla-Beltrán H; Madrigal JLM; García-Bueno B; Leza JC; Caso JR
Mol Neurobiol; 2019 Jan; 56(1):490-501. PubMed ID: 29725904
[TBL] [Abstract][Full Text] [Related]
19. Deficit, but Not Nondeficit, Schizophrenia Is Characterized by Mucosa-Associated Activation of the Tryptophan Catabolite (TRYCAT) Pathway with Highly Specific Increases in IgA Responses Directed to Picolinic, Xanthurenic, and Quinolinic Acid.
Kanchanatawan B; Sirivichayakul S; Ruxrungtham K; Carvalho AF; Geffard M; Ormstad H; Anderson G; Maes M
Mol Neurobiol; 2018 Feb; 55(2):1524-1536. PubMed ID: 28181189
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the antioxidant properties of tryptophan and its metabolites in in vitro assay.
Nayak BN; Buttar HS
J Complement Integr Med; 2016 Jun; 13(2):129-36. PubMed ID: 26641976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
